Literature DB >> 23961951

Laparoendoscopic single-site surgery with a single channel versus conventional laparoscopic varicocele ligation: a prospective randomized study.

Jian Wang1, Boxin Xue, Yu-xi Shan, Yong Cui, Wei Tao, Jin Zhu, Xiaolong Liu, Qiu Yao.   

Abstract

PURPOSE: The objective of this study was to evaluate the safety and feasibility of single channel laparoscopy in the treatment of patients with varicocele. PATIENTS AND METHODS: Ninety patients with clinically palpable varicoceles were randomly assigned to receive laparoendoscopic single-site with a single channel varicocele ligation (LESS[sc]-VL) (n=45) or conventional transperitoneal laparoscopic varicocele ligation (CTL-VL) (n=45). Patient characteristics, perioperative details, total procedural cost, time to return to work, visual analogue scale (VAS) pain score, semen parameters, and cosmetic results were recorded.
RESULTS: There were no differences in operative time (P=0.102), postoperative hospitalization time (P=0.130), total cost (P=0.112), or postoperative complications (P>0.05) between the two groups. Time to return to normal activities was shorter in the LESS(sc)-VL group than that in the CTL-VL group (P=0.018). The mean of all semen parameters were improved statistically 3 months after ligation (P<0.001). The VAS incision pain score was significantly lower 6 and 24 hours after surgery in patients who underwent LESS(sc)-VL(P<0.05). Patients who underwent LESS(sc)-VL had a better cosmetic result, reflected by both the verbal response scale and the numeric scale (P=0.008 and P=0.005, respectively).
CONCLUSIONS: LESS(sc)-VL is a safe and effective minimally invasive surgical alternative for varicocelectomy. Compared with CTL-VL, LESS(sc)-VL may decrease postoperative pain and hide the surgical incision better within the umbilicus.

Entities:  

Mesh:

Year:  2013        PMID: 23961951     DOI: 10.1089/end.2013.0237

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  6 in total

1.  Outcome of Gynecologic Laparoendoscopic Single-Site Surgery with a Homemade Device and Conventional Laparoscopic Instruments in a Chinese Teaching Hospital.

Authors:  Xianghui Su; Xiaolong Jin; Canliang Wen; Qiong Xu; Chunfang Cai; Zhuohui Zhong; Xiang Tang
Journal:  Biomed Res Int       Date:  2020-01-20       Impact factor: 3.411

Review 2.  Outcome reporting across randomized controlled trials evaluating potential treatments for male infertility: a systematic review.

Authors:  Michael P Rimmer; Ruth A Howie; Venkatesh Subramanian; Richard A Anderson; Ricardo Pimenta Bertolla; Yusuf Beebeejaun; Pietro Bortoletto; Sesh K Sunkara; Rod T Mitchell; Allan Pacey; Madelon van Wely; Cindy M Farquhar; James M N Duffy; Craig Niederberger
Journal:  Hum Reprod Open       Date:  2022-03-04

Review 3.  Laparoendoscopic single-site varicocelectomy compared with conventional laparoscopic surgery: a systematic review and meta-analysis.

Authors:  Tao Wu; Xi Duan; Xuesong Yang; Xianzhong Deng; Shu Cui
Journal:  Springerplus       Date:  2016-09-05

4.  Laparoendoscopic single-site surgery varicocelectomy versus conventional laparoscopic varicocele ligation: A meta-analysis.

Authors:  Mingchao Li; Zhengyun Wang; Hao Li
Journal:  J Int Med Res       Date:  2016-09-29       Impact factor: 1.671

Review 5.  Comparison of surgical effect and postoperative patient experience between laparoendoscopic single-site and conventional laparoscopic varicocelectomy: a systematic review and meta-analysis.

Authors:  Zheng Zhang; Shu-Juan Zheng; Wen Yu; You-Feng Han; Hai Chen; Yun Chen; Yu-Tian Dai
Journal:  Asian J Androl       Date:  2017 Mar-Apr       Impact factor: 3.285

6.  Prospective randomized comparison of transumbilical two-port laparoscopic and conventional laparoscopic varicocele ligation.

Authors:  Guo-Xi Zhang; Jun Yang; Da-Zhi Long; Min Liu; Xiao-Feng Zou; Yuan-Hu Yuan; Ri-Hai Xiao; Yi-Jun Xue; Xin Zhong; Quan-Liang Liu; Fo-Lin Liu; Bo Jiang; Rui-Quan Xu; Kun-Lin Xie
Journal:  Asian J Androl       Date:  2017 Jan-Feb       Impact factor: 3.285

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.